Last checked at 12 Feb 2020 09:10
Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses
Oncimmune Half-Year Loss Widens As Business "Reshaping" Ups Expenses
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Oncimmune Share News (ONC)
ONC Share
Price
ONC Share
News
ONC Share
Chat
ONC Share
Trades2
ONC
Live RNS1
ONC Share
Charts
ONC Level 2
Console
ONC Live
Share Price
ONC Broker
Ratings
ONC Directors
Deals
ONC Financial
Diary
ONC
Fundamentals
ONC Short
Positions
ONC
Media
Oncimmune Information
Share Price Information for Oncimmune (ONC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
24.50
Bid:
22.20
Ask:
25.00
Change:
0.00 (0.00%)
Spread:
2.80 (12.613%)
Open:
24.50
High:
0.00
Low:
0.00
Prev. Close:
24.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.28 Jan 2020 13:52
Oncimmune Reports Study Results For Cancer Test Product
Oncimmune Reports Study Results For Cancer Test Product
Read more22 Nov 2019 16:05
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more1 Nov 2019 13:33
Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test
Oncimmune And Biodesix Complete US Agreement For Lung Cancer Test
Read more31 Oct 2019 11:38
Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress
Oncimmune Annual Loss Deepens On Costs But Makes Operational Progress
Read more25 Sep 2019 11:32
CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility
CORRECT (Sep 20): Oncimmune Secures EUR8.5 Million Credit Facility
Read more23 Sep 2019 16:08
Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks
Oncimmune Adds Former Glaxo And Astra Seniors To Leadership Ranks
Read more20 Sep 2019 15:47
Oncimmune funded into 2021 with new EUR 8.5m facility
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has secured a credit facility of €8.5m (£7.5m) with IPF Management, it announced on Friday.
Read more20 Sep 2019 14:04
Oncimmune Secures EUR8.5 Billion Debt For Products Commercialisation
(Alliance News) - Oncimmune Holdings PLC on Friday said it has secured a credit facility of EUR8.5 million with IPF Management SA.The immunodiagnostics company said it will immediately draw
Read more9 Sep 2019 12:07
Oncimmune "Thrilled" With EarlyCDT Lung Cancer Test Trial Result
(Alliance News) - Oncimmune Holdings PLC on Monday announced positive results from a trial of its EarlyCDT Lung test to detect early stage lung cancer.Shares in Oncimmune were up 5.5% at in
Read more15 Jul 2019 12:55
Oncimmune Further Expands EarlyCDT Lung Sales In Spain Through Vithas
(Alliance News) - Oncimmune Holdings PLC on Monday said Sabartech SL, its existing distributor in Spain and Portugal, has agreed with Vithas Group to sell EarlyCDT Lung as a screening test for of
Read more28 Jun 2019 11:03
Oncimmune sells US operations to and partners with Biodesix
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has entered into an exclusive partnership agreement, it announced on Friday, which it said could "unlock the full potential" of its 'EarlyCDT Lung' product in the United States.
Read more26 Jun 2019 10:58
Oncimmune confident of 'material profitable revenues'
(Sharecast News) - Immunodiagnostics firm Oncimmune told investors on Wednesday it was confident it could generate "material profitable revenues" on the back of several business developments.
Read more4 Jun 2019 09:56
Oncimmune Holdings Reports Positive Lung Cancer Study Results
LONDON (Alliance News) - Oncimmune Holdings PLC on Tuesday reported positive top line results from its early cancer detection test in patients with lung cancer.Oncimmune Holdings shares at
Read more15 May 2019 15:27
Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel
(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the 'EarlyCDT-Lung' product in Israel.
Read more